Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
From Representative to Business visionary: Private issue Victories - 2Guinea-Bissau's coup called a 'sham' by West African political figures
- 3Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
- 4Vote in favor of your Favored Travel Movement
- 5Extravagance SUVs for Seniors: Solace, Innovation, and Security
- Improving as a Pioneer: Examples from My Vocation
- 5 Signs Now is the ideal time to Update Your Android Telephone: When to Take the Action
- Meet the Stars of the Feline World: Well known Pet Feline Varieties
- Pope Leo XIV calls for urgent climate action and says God’s creation is 'crying out'
- Figure out how to Consolidate All encompassing Practices with a Degree in Brain research
- Zelensky sees new Russian attack threat from Belarus
- Journeys That could only be described as epic: Delightful Voyage Lines All over the Planet
- Ten Awesome Authentic Realities That Will Leave You Interested
- Top 20 Wellbeing and Wellness Applications for a Sound Way of life
